Association of the circadian factor Period 2 to p53 influences p53's function in DNA-damage signaling

被引:49
作者
Gotoh, Tetsuya [1 ]
Vila-Caballer, Marian [1 ]
Liu, Jingjing [1 ]
Schiffhauer, Samuel [1 ]
Finkielstein, Carla V. [1 ]
机构
[1] Virginia Polytech Inst & State Univ, Dept Biol Sci, Integrated Cellular Responses Lab, Blacksburg, VA 24061 USA
基金
美国国家科学基金会;
关键词
TUMOR SUPPRESSION; CLOCK; GENE; COMPONENT; MUTATION; PROTEIN; DEGRADATION; EXPRESSION; PLAYS; BMAL1;
D O I
10.1091/mbc.E14-05-0994
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Circadian period proteins influence cell division and death by associating with checkpoint components, although their mode of regulation has not been firmly established. hPer2 forms a trimeric complex with hp53 and its negative regulator Mdm2. In unstressed cells, this association leads to increased hp53 stability by blocking Mdm2-dependent ubiquitination and transcription of hp53 target genes. Because of the relevance of hp53 in checkpoint signaling, we hypothesize that hPer2 association with hp53 acts as a regulatory module that influences hp53's downstream response to genotoxic stress. Unlike the trimeric complex, whose distribution was confined to the nuclear compartment, hPer2/hp53 was identified in both cytosol and nucleus. At the transcriptional level, a reporter containing the hp21(WAF1/CIP1) promoter, a target of hp53, remained inactive in cells expressing a stable form of the hPer2/hp53 complex even when treated with gamma-radiation. Finally, we established that hPer2 directly acts on the hp53 node, as checkpoint components upstream of hp53 remained active in response to DNA damage. Quantitative transcriptional analyses of hp53 target genes demonstrated that unbound hp53 was absolutely required for activation of the DNA-damage response. Our results provide evidence of the mode by which the circadian tumor suppressor hPer2 modulates hp53 signaling in response to genotoxic stress.
引用
收藏
页码:359 / 372
页数:14
相关论文
共 50 条
  • [31] Loss of p53 activates thyroid hormone via type 2 deiodinase and enhances DNA damage
    Nappi, Annarita
    Miro, Caterina
    Pezone, Antonio
    Tramontano, Alfonso
    Di Cicco, Emery
    Sagliocchi, Serena
    Cicatiello, Annunziata Gaetana
    Murolo, Melania
    Torabinejad, Sepehr
    Abbotto, Elena
    Caiazzo, Giuseppina
    Raia, Maddalena
    Stornaiuolo, Mariano
    Antonini, Dario
    Fabbrocini, Gabriella
    Salvatore, Domenico
    Avvedimento, Vittorio Enrico
    Dentice, Monica
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [32] Assessing dose-dependent differences in DNA-damage, p53 response and genotoxicity for quercetin and curcumin
    Sun, Bin
    Ross, Susan M.
    Trask, O. Joseph
    Carmichael, Paul L.
    Dent, Matthew
    White, Andrew
    Andersen, Melvin E.
    Clewell, Rebecca A.
    TOXICOLOGY IN VITRO, 2013, 27 (06) : 1877 - 1887
  • [33] DAZAP2 acts as specifier of the p53 response to DNA damage
    Liebl, Magdalena C.
    Moehlenbrink, Jutta
    Becker, Huong
    Raddatz, Guenter
    Abdeen, Suhaib K.
    Aqeilan, Rami, I
    Lyko, Frank
    Hofmann, Thomas G.
    NUCLEIC ACIDS RESEARCH, 2021, 49 (05) : 2759 - 2776
  • [34] Dual regulation of p53 by the ribosome maturation factor SBDS
    Hao, Qian
    Wang, Jieqiong
    Chen, Yajie
    Wang, Shanshan
    Cao, Mingming
    Lu, Hua
    Zhou, Xiang
    CELL DEATH & DISEASE, 2020, 11 (03)
  • [35] p53 loss-of-heterozygosity is a necessary prerequisite for mutant p53 stabilization and gain-of-function in vivo
    Alexandrova, Evguenia M.
    Mirza, Safia A.
    Xu, Sulan
    Schulz-Heddergott, Ramona
    Marchenko, Natalia D.
    Moll, Ute M.
    CELL DEATH & DISEASE, 2017, 8 : e2661 - e2661
  • [36] Mutant p53 Gain of Function and Chemoresistance: The Role of Mutant p53 in Response to Clinical Chemotherapy
    He, Chao
    Li, Lun
    Guan, Xuan
    Xiong, Li
    Miao, Xiongying
    CHEMOTHERAPY, 2017, 62 (01) : 43 - 53
  • [37] p53 mRNA and p53 Protein Structures Have Evolved Independently to Interact with MDM2
    Karakostis, Konstantinos
    Ponnuswamy, Anand
    Fusee, Leila T. S.
    Bailly, Xavier
    Laguerre, Laurent
    Worall, Erin
    Vojtesek, Borek
    Nylander, Karin
    Fahraeus, Robin
    MOLECULAR BIOLOGY AND EVOLUTION, 2016, 33 (05) : 1280 - 1292
  • [38] HBV DNA can bind to P53 protein and influence p53 transactivation in hepatoma cells
    Qu, Jianhui
    Lin, Jing
    Zhang, Shuhui
    Zhu, Zhi
    Ni, Canrong
    Zhang, Shunmin
    Gao, Hengjun
    Zhu, Minghua
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 386 (03) : 504 - 509
  • [39] p53 signaling in cancer progression and therapy
    Marei, Hany E.
    Althani, Asmaa
    Afifi, Nahla
    Hasan, Anwarul
    Caceci, Thomas
    Pozzoli, Giacomo
    Morrione, Andrea
    Giordano, Antonio
    Cenciarelli, Carlo
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [40] Association of P53 codon 72 polymorphism and ameloblastoma
    Kitkumthorn, N.
    Yanatatsaneejit, P.
    Rabalert, J.
    Dhammawipark, C.
    Mutirangura, A.
    ORAL DISEASES, 2010, 16 (07) : 631 - 635